Join our community of smart investors

Positive trial data for Oxford/AstraZeneca vaccine

Shares in the pharma group climbed on the encouraging news
Positive trial data for Oxford/AstraZeneca vaccine

A Covid-19 vaccine being developed by Oxford University and AstraZeneca (AZN) has achieved positive results in early-stage trials. The potential inoculation was shown to produce a strong immune response, with no indication of safety concerns.

IC TIP: Buy at 9510p

To continue reading...
OR
Register for free
Read 3 articles for free each month
* Excl. premium articles
Have an account? Sign in